A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).
Version 2 2024-06-06, 05:21Version 2 2024-06-06, 05:21
Version 1 2023-03-17, 05:05Version 1 2023-03-17, 05:05
conference contribution
posted on 2024-06-06, 05:21 authored by Ann LivingstoneAnn LivingstoneA Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).
History
Journal
Neuro-OncologyISSN
1522-8517Publication classification
E3.1 Extract of paperTitle of proceedings
Neuro-OncologyPublisher
Oxford University Press (OUP)Usage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC